Akkermansia muciniphila inactivated & Metabolic syndrome (MetS)

Conclusions from randomized clinical trials (RCTs)

• NCT05114018 - Akkermansia muciniphila MucT TM & Metabolic syndrome (MetS)

For this randomized clinical treatment trial, no published were found as of March 2026

• NCT02637115 - Microbes4U - Akkermansia muciniphila vs Akkermansia muciniphila (killed) vs placebo & Metabolic Syndrome (MetS)

This randomized clinical basic science trial highlights the potential benefits of Akkermansia muciniphila inactivated in improving metabolic health markers, with significant effects on insulin sensitivity, cholesterol levels, and body composition.
Depommier et al. 2019 Nat Med. 25(7): 1096-1103

see also:
Akkermansia muciniphila & Metabolic Syndrome (MetS)
Metabolic Syndrome (MetS) & Drugs/Treatments
Postbiotics & Metabolic Syndrome (MetS)